Notably, PD-1 blockade on CD8+ TRM cells, freshly isolated from human lung cancer, promoted a strong MHC-I-restricted cytolytic activity against autologous tumor cells ex vivo, which was impaired by blocking CD103 interaction with target cells [103]. This evidence concerns the gene CD8A and lung cancer.